RSS feed (help and list of feeds)
Consultation
We ask for feedback on proposals through public consultation, and take into account all consultation responses we receive before making our decisions. PHARMAC has published guidance for consumers on getting involved in our decisions, and this includes responses to consultation. You can download the document here (8 pages, 100 KB).
We welcome feedback from pharmaceutical suppliers, health professionals, health interest groups and the general public. This page includes consultations that are currently underway.
You can respond to a consultation by writing to the address at the bottom of the consultation letter. Notifications of the outcomes of closed consultations are available here.
Rapid response
If you would like to make a rapid response to any of our consultations, click 
here. Remember to indicate which consultation proposal your comments relate to.
Search for previous consultation documents
-
Title Amend restrictions relating to various ophthalmology products (3 pages, 158 KB) Closing Date Wednesday 22 February 2012 Contact Greg Williams Email Greg.Williams@pharmac.govt.nz
-
Title Proposal to fund lapatinib and pazopanib and amend funding criteria for trastuzumab (7 pages, 154 KB) Closing Date 5pm, Thursday 9 February 2012 Contact Jackie Evans Email Jackie.Evans@pharmac.govt.nz
-
Title Widen access to ursodeoxycholic acid (2 pages, 126 KB) Closing Date Closed Contact Natalie Davis Email Natalie.Davis@pharmac.govt.nz
-
Title Proposal to fully fund Symbicort Turbuhaler and Vannair (3 pages, 127 KB) Closing Date Closed Contact Christine Chapman Email Christine.Chapman@pharmac.govt.nz
-
Title Proposal to amend the listing of benztropine mesylate injections (2 pages, 110 KB) Closing Date Closed Contact Natalie Davis Email Natalie.Davis@pharmac.govt.nz
-
Title Feedback on draft Records Retention and Disposal Schedule (1 page, 79 KB) Closing Date Closed Contact Davina Carpenter Email Davina.Carpenter@pharmac.govt.nz
-
Title List Jaychem's Chlorhexidine in Alcohol in Section H (1 page, 106 KB) Closing Date Closed Contact Andrew Davies Email Andrew.Davies@pharmac.govt.nz
-
Title Candesartan - Access widening and sole supply (3 pages, 108 KB) Closing Date Closed Contact Stephen Woodruffe Email Stephen.Woodruffe@pharmac.govt.nz
-
Title Proposal for the funding of an additional brand of adrenaline injection (1 page, 133 KB) Closing Date Closed Contact Stephen Woodruffe Email Stephen.Woodruffe@pharmac.govt.nz
-
Title Proposal for sole supply of Respiratory Devices (3 pages, 149 KB) Closing Date Closed Contact Christine Chapman Email Christine.Chapman@pharmac.govt.nz
-
Title Proposal to amend the rules relating to Discretionary Community Supply (2 pages, 108 KB) Closing Date Closed Contact Sean Dougherty Email Sean.Dougherty@pharmac.govt.nz
-
Title Proposal to cease Schedule publication in Microsoft Access format (2 pages, 125 KB) Closing Date Closed Contact John Geering Email John.Geering@pharmac.govt.nz
-
Title Amending access criteria for lignocaine containing urethral syringes (1 page, 101 KB) Closing Date Closed Contact Geraldine MacGibbon Email Geraldine.MacGibbon@pharmac.govt.nz
-
Title Sole supply of metoprolol (3 pages, 99 KB) Closing Date Closed Contact Stephen Woodruffe Email Stephen.Woodruffe@pharmac.govt.nz
-
Title Proposal relating to risperidone and quetiapine (2 pages, 115 KB) Closing Date Closed Contact Geraldine MacGibbon Email Geraldine.MacGibbon@pharmac.govt.nz
-
Title Consultation on provisional agreement with CSL Biotherapies (3 pages, 133 KB) Closing Date Closed Contact Greg Williams Email Greg.Williams@pharmac.govt.nz
-
Title Proposal to amend the terms of listing for efavirenz (1 page, 110 KB) Closing Date Closed Contact Greg Williams Email Greg.Williams@pharmac.govt.nz
-
Title Proposal relating to four opthalmological products (2 pages, 125 KB) Closing Date Closed Contact Sue Anne Yee Email SueAnne.Yee@pharmac.govt.nz
-
Title Proposal on subsidy changes and access for some respiratory products (5 pages, 149 KB) Closing Date Closed Contact Christine Chapman Email Christine.Chapman@pharmac.govt.nz
-
Title Proposal to amend General Rules in the Pharmaceutical Schedule (6 pages, 145 KB) Closing Date Closed Contact Rebecca Bloor Email Rebecca.Bloor@pharmac.govt.nz
Page updated on 09 Feb 2012
Linked documents
Having Your Say in our Decisions (8 pages, 100 KB)
Pharmaceutical Management Agency Having your say in our decisions PHARMAC’s decision-making PHARMAC is the Government agency that decides which medicines are funded for New Zealanders. We welcome input from people into our decision-making processes. There are a number of ways…
Amend restrictions relating to various ophthalmology products; Closing Date: Wednesday 22 February 2012; Contact: Greg Williams (3 pages, 158 KB)
3 February 2012 Proposal to amend restrictions relating to various ophthalmology products. PHARMAC is seeking feedback on proposals to remove the prescribing guidelines currently in Part B of the Pharmaceutical Schedule for glaucoma preparations and to include several ophthalmology products…
Proposal to fund lapatinib and pazopanib and amend funding criteria for trastuzumab; Closing Date: 5pm, Thursday 9 February 2012; Contact: Jackie Evans (7 pages, 154 KB)
26 January 2012 Proposal to fund lapatinib and pazopanib and amend funding criteria for trastuzumab PHARMAC is seeking feedback on a proposal to: Fund lapatinib (Tykerb) as an alternative to trastuzumab (Herceptin) for the first line treatment of patients…
Widen access to ursodeoxycholic acid; Closing Date: Closed; Contact: Natalie Davis (2 pages, 126 KB)
20 January 2012 Proposal to widen access to ursodeoxycholic acid PHARMAC is seeking feedback on a proposal to widen funded access to ursodeoxycholic acid for prevention of veno-occlusive disease in patients receiving high dose conditioning therapy prior to bone marrow…
Proposal to fully fund Symbicort Turbuhaler and Vannair; Closing Date: Closed; Contact: Christine Chapman (3 pages, 127 KB)
17 January 2012 Proposal to fully fund Symbicort Turbuhaler and Vannair PHARMAC is seeking feedback on a proposal to fully subsidise budesonide with eformoterol (Symbicort Turbuhaler and Vannair) from 1 March 2012 through a provisional agreement with AstraZeneca. In summary,…
Proposal to amend the listing of benztropine mesylate injections; Closing Date: Closed; Contact: Natalie Davis (2 pages, 110 KB)
5 December 2011 Proposal to amend the listing of benztropine mesylate injections PHARMAC has signed a provisional agreement with Invida Australia Pty Ltd and is seeking feedback on the following proposals relating to benztropine mesylate (Cogentin) injections: benztropine mesylate…
Feedback on draft Records Retention and Disposal Schedule; Closing Date: Closed; Contact: Davina Carpenter (1 page, 79 KB)
28 November 2011 Feedback on draft Records Retention and Disposal Schedule PHARMAC is seeking feedback on our records retention and disposal schedule and the report that must accompany the schedule when it is submitted to Archives New Zealand. In summary,…
List Jaychem's Chlorhexidine in Alcohol in Section H; Closing Date: Closed; Contact: Andrew Davies (1 page, 106 KB)
21 November 2011 Proposal to list Jaychem’s Chlorhexidine in Alcohol in Section H of the Pharmaceutical Schedule PHARMAC and Jaychem Industries Ltd have entered into a provisional agreement for chlorhexidine in alcohol. This proposal would result in a 500 ml…
Candesartan - Access widening and sole supply; Closing Date: Closed; Contact: Stephen Woodruffe (3 pages, 108 KB)
27 October 2011 Candesartan - Special Authority Removal and Sole Supply PHARMAC is seeking feedback on the following proposals relating to candesartan following a Request for Proposals issued in September 2011. In summary, these proposals would result in: Price and…
Proposal for the funding of an additional brand of adrenaline injection; Closing Date: Closed; Contact: Stephen Woodruffe (1 page, 133 KB)
18 October 2011 Proposal for the funding of an additional brand of adrenaline (1:10,000) injection Proposal summary PHARMAC and Aspen Pharmacare Australia Pty Limited have entered into a provisional agreement for Aspen’s adrenaline injection 1 in 10,000, 10 ml (Aspen…
Proposal for sole supply of Respiratory Devices; Closing Date: Closed; Contact: Christine Chapman (3 pages, 149 KB)
14 October 2011 Proposal for sole supply of Respiratory Devices (peak flow meters, spacer devices, paediatric masks) As a result of a request for proposals (RFP) for the sole supply of peak flow meters, spacer devices and paediatric masks for…
Proposal to amend the rules relating to Discretionary Community Supply; Closing Date: Closed; Contact: Sean Dougherty (2 pages, 108 KB)
13 October 2011 Proposal to amend the rules relating to Discretionary Community Supply PHARMAC is seeking feedback on a proposal to widen the circumstances under which DHB hospitals can provide non-DCS Pharmaceuticals to patients for use in the community without…
Proposal to cease Schedule publication in Microsoft Access format; Closing Date: Closed; Contact: John Geering (2 pages, 125 KB)
11 October 2011 Proposal to Cease Schedule publication in Microsoft Access format PHARMAC is seeking feedback on a proposal to reduce the number of formats in which the Pharmaceutical Schedule is published. In particular it is proposed to cease publication…
Amending access criteria for lignocaine containing urethral syringes; Closing Date: Closed; Contact: Geraldine MacGibbon (1 page, 101 KB)
3 October 2011 Proposal to amend the access criteria for lignocaine-containing urethral syringes PHARMAC is seeking feedback on a proposal to add an endorsement restriction to the listings of lignocaine gel 2%, 10 ml urethral syringe (Pfizer) and lignocaine gel…
Sole supply of metoprolol; Closing Date: Closed; Contact: Stephen Woodruffe (3 pages, 99 KB)
30 September 2011 Sole Supply of Metoprolol Succinate and Metoprolol Tartrate PHARMAC is seeking feedback on the following sole supply proposals for metoprolol succinate (tablets) and metoprolol tartrate (tablets and injection) arising from our Request for Proposals for these products…
Proposal relating to risperidone and quetiapine; Closing Date: Closed; Contact: Geraldine MacGibbon (2 pages, 115 KB)
23 September 2011 Proposal to re-apply reference pricing across brands of risperidone and quetiapine PHARMAC is seeking feedback on a proposal to re-apply reference pricing across different brands of risperidone tablets and oral liquid and across different brands of quetiapine…
Consultation on provisional agreement with CSL Biotherapies; Closing Date: Closed; Contact: Greg Williams (3 pages, 133 KB)
22 September 2011 Proposal relating to betamethasone diproprionate with calcipotriol, calcipotriol, fusidic acid and bumetanide. PHARMAC is seeking feedback on a proposal to fund betamethasone diproprionate with calcipotriol (Daivobet) through a provisional agreement with CSL Biotherapies (NZ) Limited. This proposal…
Proposal to amend the terms of listing for efavirenz; Closing Date: Closed; Contact: Greg Williams (1 page, 110 KB)
22 September 2011 Proposal to amend the terms of listing for efavirenz Following a request to pharmaceutical suppliers for commercial proposals as an alternative to tendering certain pharmaceuticals for sole supply, PHARMAC and Merck Sharp and Dohme (New Zealand) Limited…
Proposal relating to four opthalmological products; Closing Date: Closed; Contact: Sue Anne Yee (2 pages, 125 KB)
14 September 2011 Proposal relating to bimatoprost, brimonidine tartrate with timolol maleate and prednisolone acetate PHARMAC is seeking feedback on a proposal relating to a provisional agreement with Allergan Australia Pty Ltd for four ophthalmological products. In summary, this proposal…
Proposal on subsidy changes and access for some respiratory products; Closing Date: Closed; Contact: Christine Chapman (5 pages, 149 KB)
30 August 2011 Proposal on subsidy changes for some respiratory inhalation products and access restrictions to combination inhalers. As notified on 16 June 2011, PHARMAC has been considering options for managing the funding of the inhaled corticosteroids (ICS) and long-acting…
Proposal to amend General Rules in the Pharmaceutical Schedule; Closing Date: Closed; Contact: Rebecca Bloor (6 pages, 145 KB)
19 August 2011 Proposal to amend the General Rules in the Pharmaceutical Schedule PHARMAC is seeking feedback on a proposal to amend the General Rules in the Pharmaceutical Schedule. The intention of this proposal is to reduce some of the…
